Items where Author is "Serve, H."

Article

Mueller-Tidow, C. and Tschanter, P. and Roellig, C. and Thiede, C. and Koschmieder, A. and Stelljes, M. and Koschmieder, S. and Dugas, M. and Gerss, J. and Butterfass-Bahloul, T. and Wagner, R. and Eveslage, M. and Thiem, U. and Krause, S. W. and Kaiser, U. and Kunzmann, V. and Steffen, B. and Noppeney, R. and Herr, W. and Baldus, C. D. and Schmitz, N. and Goetze, K. and Reichle, A. and Kaufmann, M. and Neubauer, A. and Schaefer-Eckart, K. and Haenel, M. and Peceny, R. and Frickhofen, N. and Kiehl, M. and Giagounidis, A. and Goerner, M. and Repp, R. and Link, H. and Kiani, A. and Naumann, R. and Bruemmendorf, Th and Serve, H. and Ehninger, G. and Berdel, W. E. and Krug, U. (2016) Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia. LEUKEMIA, 30 (3). pp. 555-561. ISSN 0887-6924, 1476-5551

Krug, U. and Berdel, W. E. and Gale, R. P. and Haferlach, C. and Schnittger, S. and Mueller-Tidow, C. and Braess, J. and Spiekermann, K. and Staib, P. and Beelen, D. and Serve, H. and Schliemann, C. and Stelljes, M. and Balleisen, L. and Maschmeyer, G. and Grueneisen, A. and Eimermacher, H. and Giagounidis, A. and Rasche, H. and Hehlmann, R. and Lengfelder, E. and Thiel, E. and Reichle, A. and Aul, C. and Ludwig, W-D and Kern, W. and Haferlach, T. and Koepcke, W. and Goerlich, D. and Sauerland, M. C. and Heinecke, A. and Woermann, B. J. and Hiddemann, W. and Buechner, T. (2016) Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia. LEUKEMIA, 30 (6). pp. 1230-1236. ISSN 0887-6924, 1476-5551

Fiegl, M. and Unterhalt, M. and Kern, W. and Braess, J. and Spiekermann, K. and Staib, P. and Grueneisen, A. and Woermann, B. and Schoendube, D. and Serve, H. and Reichle, A. and Hentrich, M. and Schiel, X. and Sauerland, C. and Heinecke, A. and Rieger, C. and Beelen, D. and Berdel, W. E. and Buechner, T. and Hiddemann, W. (2014) Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG. LEUKEMIA, 28 (5). pp. 1001-1007. ISSN 0887-6924, 1476-5551

Braess, J. and Spiekermann, K. and Staib, P. and Kreuzer, K. A. and Grueneisen, A. and Woermann, B. and Ludwig, W. -D. and Serve, H. and Reichle, A. and Peceny, R. and Oruzio, D. and Schmid, Ch. and Schiel, X. and Hentrich, M. and Sauerland, Ch. and Unterhalt, M. and Fiegl, M. and Kern, W. and Buske, C. H. and Bohlander, S. T. and Heinecke, A. and Baurmann, H. and Beelen, D. W. and Berdel, W. E. and Buechner, Th. and Hiddemann, W. (2011) The Relevance of Dose and Dose-Density in Induction Chemotherapy Exemplified by High-Dose Cytarabine and Mitoxantrone containing Regimens in Either Standard Double Induction or Dose-Dense Induction - An Analysis of the AML-CG. ANNALS OF HEMATOLOGY, 90 (Suppl1). S39-S40. ISSN 0939-5555

Lengfelder, Eva and Haferlach, C. and Saussele, S. and Haferlach, T. and Schultheis, B. and Schnittger, S. and Ludwig, W-D and Staib, P. and Aul, C. and Grueneisen, A. and Kern, W. and Reichle, A. and Serve, H. and Berdel, W. E. and Braess, J. and Spiekermann, K. and Woermann, B. and Sauerland, M-C and Heinecke, A. and Hiddemann, W. and Hehlmann, R. and Buechner, T. (2009) High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. LEUKEMIA, 23 (12). pp. 2248-2258. ISSN 0887-6924, 1476-5551

Teller, S. and Kraemer, D. and Boehmer, S. A. and Tse, K. F. and Small, D. and Mahboobi, Siavosh and Wallrapp, C. and Beckers, T. and Kratz-Albers, K. and Schwable, J. and Serve, H. and Boehmer, F. D. (2002) Bis(1 H-2-indolyl)-1-methanones as inhibitors of the hematopoietic tyrosine kinase Flt3. LEUKEMIA, 16 (8). pp. 1528-1534. ISSN 0887-6924

Other

Roellig, C. and Serve, H. and Huettmann, A. and Noppeney, R. and Mueller-Tidow, C. and Krug, U. and Baldus, C. D. and Brandts, C. H. and Kunzmann, V and Einsele, H. and Kraemer, A. and Schaefer-Eckart, K. and Neubauer, A. and Burchert, A. and Giagounidis, A. and Krause, S. W. and Mackensen, A. and Aulitzky, W. and Herbst, R. and Haenel, M. and Kiani, A. and Frickhofen, N. and Kullmer, J. and Kaiser, U. and Link, H. and Geer, T. and Reichle, A. and Junghanss, C. and Bornhaeuser, M. and Schaich, M. and Thiede, C. and Schetelig, J. and Kramer, M. and Berdel, W. E. and Ehninger, G. (2018) The addition of sorafenib to standard AML treatment results in a substantial reduction in relapse risk and improved survival. Updated results from long-term follow-up of the randomized-controlled SORAML trial. KARGER, BASEL.

Platzbecker, U. and Lengfelder, E. and Goetze, K. and Roellig, C. and Kramer, M. and Sauer, M. and Albers, N. and Heuser, M. and Link, H. and Schaefer-Eckart, K. and Martin, S. and Krause, S. and Haenel, M. and Bochtler, T. and Jakob, A. and Reichle, A. and Biersack, H. and Baldus, C. and Goerner, M. and Basara, N. and Mezger, J. and Naumann, R. and Kuerschner, D. and de Wit, M. and Nolte, F. and Scholl, S. and Ringhoffer, M. and Tischler, H. J. and Greiner, J. and Kremers, S. and Machherndl-Spandl, S. and Koller, E. and Wattad, M. and Aschauer, G. and Radsak, M. and Kubin, T. and Salih, H. and Wolf, D. and Thiede, C. and Serve, H. and Duehrsen, U. and Hochhaus, A. and Bruemmendorf, T. and Bornhaeuser, M. and Doehner, H. and Ehninger, G. and Schlenk, R. F. (2016) Real life experience with ATRA-arsenic trioxide based regimen in acute promyelocytic leukemia - results of the prospective German intergroup Napoleon registry. KARGER, BASEL.

Tschanter, P. and Krug, U. and Fueller, M. and Klein, M. and Goellner, S. and Rohde, C. and Roellig, C. and Thiede, C. and Lilly, M. A. and Haack, B. and Koschmieder, A. and Stelljes, M. and Dugas, M. and Koschmieder, S. and Gerss, J. and Butterfass-Bahloul, T. and Wagner, R. and Eveslage, M. and Thiem, U. and Krause, S. W. and Kaiser, U. and Kunzmann, V and Steffen, B. and Noppeney, R. and Herr, W. and Baldus, C. D. and Schmitz, N. and Goetze, K. and Reichle, A. and Kaufmann, M. and Neubauer, A. and Schaefer-Eckart, K. and Haenel, M. and Peceny, R. and Frickhofen, N. and Kiehl, M. and Giagounidis, A. and Goerner, M. and Repp, R. and Link, H. and Kiani, A. and Naumann, R. and Bruemmendorf, T. H. and Serve, H. and Ehninger, G. and Berdel, W. E. and Mueller-Tidow, C. (2015) DNMT3A mutations in exon 23 are associated with improved survival in AML patients treated with Azacytidine plus standard chemotherapy. KARGER, BASEL.